EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients

por Borkowska, Edyta M., Jędrzejczyk, Adam, Marks, Piotr, Catto, James W.F., Kałużewski, Bogdan
Publicado 2013

Detection of loss of heterozygosity in patients with urinary bladder carcinoma: neoplastic tissue vs. urine sediment cells

por Traczyk, Magdalena, Borkowska, Edyta, Jędrzejczyk, Adam, Pietrusiński, Michał, Rożniecki, Marek, Marks, Piotr, Kałużewski, Bogdan
Publicado 2011

The prevalence of CHEK2 and CYP1B1 mutations/polymorphisms in urinary bladder cancer

por Banaszkiewicz, Monika, Constantinou, Maria, Pietrusiński, Michał, Kępczyński, Łukasz, Jędrzejczyk, Adam, Rożniecki, Marek, Marks, Piotr, Kałużewski, Bogdan
Publicado 2012

Concomitance of oncogenic HPV types, CHEK2 gene mutations, and CYP1B1 gene polymorphism as an increased risk factor for malignancy

por Banaszkiewicz, Monika, Constantinou, Maria, Pietrusiński, Michał, Kępczyński, Łukasz, Jędrzejczyk, Adam, Rożniecki, Marek, Marks, Piotr, Kałużewski, Bogdan
Publicado 2013

Artificial neural network in predicting bladder cancer recurrence

por Borkowska, Edyta, Constantinou, Maria, Jędrzejczyk, Adam, Traczyk, Magdalena, Banaszkiewicz, Monika, Pietrusiński, Michał, Marks, Piotr, Rożniecki, Marek, Kruk, Andrzej, Kałużewski, Bogdan
Publicado 2012

Polymorphic variants of H-RAS protooncogene and their possible role in bladder cancer etiology

por Traczyk, Magdalena, Borkowska, Edyta, Rożniecki, Marek, Purpurowicz, Rafał, Jędrzejczyk, Adam, Marks, Piotr, Pietrusiński, Michał, Jabłonowski, Zbigniew, Sosnowski, Marek, Kałużewski, Bogdan
Publicado 2012